 |
Curriculum Vitae
Name: David Anthony Lam, M.D., FAAD, FASMS
Place of Birth: Caverna, Kentucky
Position: Board Certified Dermatologist
Diplomat of American Board of Dermatology
Fellow of American Society for MOHS Surgery
Academic Alliance in Dermatology
5210 Webb Road
Tampa, FL 33615
Tel. 813-882-9986
Fax 813-882-9849
Citizenship: U. S. Citizen
Languages: English
Education: 1991-2003 (see below)
Undergrad: Western Kentucky University, Bowling Green, KY. 1991-1995,
Summa Cum Laude
Major: Chemistry Minor: Biology
Medical School: University of Louisville Medical School, Louisville, KY. 1995-1999,
Graduation: Summa cum Laude, May 1999.
Internship: University of Florida, Gainesville, FL, 1999-2000, Internal medicine
Residency: University of Florida, Gainesville, FL, Dermatology and Cutaneous Surgery
- Chief Resident, June 2002-June 2003
- Dermatology Resident, July 2000-June 2003
- American Board of Dermatology In-Training Exam: 2001-88%, 2002-99%ile
- Surgical Experience: over 600 excisions, over 100 flaps, 30 grafts, 100 Mohs surgeries. Extensive experience with lasers including Nd:YAG (1064nm), fd-Nd:YAG (532nm), Erbium (2940nm), Alexandrite (755nm) and Variable Pulse (532nm)
Research Experience:
Aratec Clinical Research: medication names and research were protected by confidentiality agreements.
-
Long term safety assessment of helioblock sx cream in patients with PMLE
- The safety and efficacy of adapalene gel as compared to its vehicle and adapalene gel in the treatment of acne.
- An open label study to evaluate the safety of topically applied tacrolimus ointment for the treatment of atopic dermatitis.
- A randomized, double-blind, double-dummy, placebo controlled, multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of moderate to severe age related skin changes in postmenopausal women
- A double blind, randomized, placebo controlled, multi-center trial to investigate the efficacy and safety of terbinafine HCL spray when applied twice daily for seven days in subjects with tinea pedis.
- A double blind, placebo controlled, multicenter study to determine the effect of finasteride in men with advanced male pattern hair loss.
- A two year, double blind, randomized, placebo controlled, parallel group, multicenter study to determine the efficacy and tolerability of finasteride 1mg on hair loss in men aged 41-60 with androgenetic alopecia.
Research assistant, Department of Chemistry, Western Kentucky University. Dr. Thomas Green. Methylation of petroleum distillates and NMR characteristics of identifications. 1992-1995.
Awards/Honors:
Alpha Omega Alpha-University of Louisville Chapter (1998-present)
University of Louisville Pediatrics Department Student of the Year 1999
University of Louisville Department of Physiology Student of the Year 1996
Western Kentucky University President’s Scholarship and Scholar 1991-1995
Western Kentucky University Department of Chemistry Student of the Year 1993, 1994
Western Kentucky University Department of Biology President’s Scholarship 1993, 1994, 1995
Phi Beta Kappa 1995
Board Certification: American Board of Dermatology, 2003
Hospital Affiliations:
Town & Country Dermatology, Tampa, FL
All Children’s Hospital, St. Petersburg, FL
Licensure: Florida/2002 ME 85485
Professional Organization Memberships:
American Board of Dermatology (2003-present)
American Society for Mohs Surgery (2003-present)
American Academy of Dermatology (2000-present)
Florida Society of Dermatology (2000-present)
American Medical Association (1995-1999)
Presentations:
“Goltz Syndrome”, David Lam, MD and Linda Golkar, MD. Presented at the American Academy of Dermatology, Fall meeting, New Orleans, Louisiana. March 2002.
Physician Assistant Dermatology Lecture Series, University of Florida. 2001, 2002. |
